
Sign up to save your podcasts
Or


Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.
By SMFM4.7
2424 ratings
Dr. Mandelbrodt discusses results from the TOXOGEST study, a randomized open-label trial comparing pyrimethamine/sulfadiazine to spiramycin in reduction of perinatal transmission of toxoplasma gondii. The results were presented at the SMFM Annual Pregnancy Meeting in February 2018.

66 Listeners

2,441 Listeners

3,349 Listeners

112,250 Listeners

56,677 Listeners

454 Listeners

552 Listeners

219 Listeners

101 Listeners

1,773 Listeners

66 Listeners

22 Listeners